rBIO completes analytical characterizations of insulin drug for clinical trial
Synthetic biology company rBIO has completed all required analytical characterizations of its insulin biosimilar, R-biolin.
Archives for January 29, 2024
New treatment from Vergent Bioscience able to visualize tumors in lung during surgery
Biotechnology company Vergent Bioscience has revealed that VGT-309, its investigational tumor-targeted fluorescent imaging agent, is able to help surgeons see lung tumors in real time during surgical procedures.
Moderna leads development of mRNA vaccines in infectious diseases
The global messenger ribonucleic acid (mRNA) vaccine market currently consists entirely of vaccines for COVID-19.
Syensqo invests in green chemistry start-up Bioeutectics
Green chemistry start-up Bioeutectics has bagged $2.1 million in venture capital funding to develop its green solvent technology.
IQVIA: Healthcare data regional compliance complexity requires AI, ML and NLP automation
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.